Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103
Published November 11, 2026 · Recall initiated: September 14, 2026
Summary
FDA records medical device Class II recall Z-0317-2027, published November 11, 2026 and initiated September 14, 2026. Recalling firm: Accriva Diagnostics, Inc.; Status: Ongoing; Reported quantity: 28710; Lot: UDI-DI: 10711234103012, Lot(Expiration): B6JCA005(02/28/2027), C6JCA008(03/31/2027), D6JCA011(04/30/2027), K5JCA041(10/31/2026), C6JCA007(03/31/2027). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Accriva Diagnostics, Inc.
- Distributor
- Worldwide - US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia.
- Lot
- UDI-DI: 10711234103012, Lot(Expiration): B6JCA005(02/28/2027), C6JCA008(03/31/2027), D6JCA011(04/30/2027), K5JCA041(10/31/2026), C6JCA007(03/31/2027)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATandem Mobi Insulin Pump, Models: 1004004, 1010750, 1012676, 1012719, 1013655, 1013656, 1013501, 1013700,November 11, 2026
- FDAEVOS 3.5MM LATERAL PROXIMAL TIBIA PLATE 6 HOLE LEFT 91MM REF72463106November 11, 2026
- FDAGeneric Name: Edwards Commander M Delivery System Generic Name: Edwards Commander M Delivery SystemNovember 11, 2026
- FDAEmbletta MPR PG Multi Parameter Recorder Sleep Monitor, Model/Catalog Number: 2003011November 11, 2026
- FDAdirectCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2June 24, 2026
- FDAAVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole bloodNovember 6, 2024
Questions about this recall
Was Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103 recalled?
Yes. FDA published recall Z-0317-2027 on November 11, 2026. Reported hazard: Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
What should I do if I have this product?
Voluntary: Firm initiated · Letter